Yohan Kim
Senior Managing Director @ DSC Investment
Yohan Kim is a Series B investor at DSC Investment focused on Health Care and Therapeutics. Yohan Kim
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Yohan Kim invests in
Stages Yohan Kim invests in
Countries Yohan Kim invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (50%)
- Therapeutics 2 (50%)
- Biotechnology 2 (50%)
- Pharmaceutical 2 (50%)
- Medical 1 (25%)
Stage
- Series B 3 (75%)
- Series A 1 (25%)
Country
- South Korea 2 (50%)
- United States 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology. | $47M / Series B / Oct 28, 2025 | ||
| Illimis Therapeutics is a platform-based biotech company that develops a chimeric fusion protein platform for neurodegenerative diseases. The company's proprietary GAIA (Gas6-mediated Anti-Inflammatory Adaptor) platform is designed to harness the therapeutic potential of TAM (Tyro3, Axl, Mer) receptor biology, a critical pathway involved inregulating inflammation and immune responses. | $41.9M / Series B / Jul 14, 2025 | ||
| MicrobiotiX develops bacteriophage and microbiome-based therapeutics to combat multidrug-resistant infections and autoimmune diseases. | $10.9M / Series B / Oct 21, 2024 | ||
| PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology. | $17M / Series A / Jul 30, 2024 |
Co-Investors
About DSC Investment
DSC Investments invests in early stage and growth companies in the field of corporate identify and focus, IT, software, biotechnology, machinery, and future high-growth areas such as environment and resources.
DSC Investment Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Han Tae Hoon
Managing Director
|
|||
Junam Kim
Director
|
|||
|
Kyungho Lee
Managing Director
|
|||
|
Lee Yong-hyun
Head of the DSC Investment team
|
|||
|
Yohan Kim
Senior Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Yohan Kim invest in?
Yohan Kim invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series B and Series A stage. Most of the 4 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Yohan Kim?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Yohan Kim last invest?
The most recent investment recorded for Yohan Kim closed in Oct 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
